Company: CERO
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001213900-25-032134
Chunk: 2580

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 6
Chunk 2580
---
)  
    (Predecessor) 
  
    Right-of-use assets, net 
    $1,464,367  
    $2,189,565 

The operating lease liability for the operating lease was recorded
in the consolidated balance sheets as follows:

     December 31,   December 31,      2024   2023      (Successor)   (Predecessor)   Operating lease liabilities, current  $876,392   $769,092   Operating lease liabilities, non-current   699,107    1,575,499   Total operating lease liabilities  $1,575,499   $2,344,591                Weighted-average remaining lease term of operating leases (in years)   1.75    2.75   Weighted-average discount rate for operating leases   9.60%   9.60% 

F-17

The following table reconciles the undiscounted future minimum lease
payments under the non-cancelable operating lease with terms of more than one year to the total operating lease liabilities recognized
on the Company’s balance sheet as of December 31, 2024:

Maturity of the Company’s lease liabilities as of December 31, 2024 is as follows: 

    2025 
    $990,055 
  
    2026 
     726,394 
  
    Total lease payments 
     1,716,449 
  
    Less: imputed interest 
     (140,950)
  
    Total lease liabilities 
    $1,575,499 

NOTE
8 – STOCKHOLDERS’ DEFICIT

Successor Series A Convertible Preferred Stock

The Company designated 12,580
shares of its authorized preferred stock as the Series A Preferred Stock and the rights, preferences and privileges of the Series A Preferred
Stock are summarized below.

Each share of Series A Preferred
Stock has a stated value of $1,000 per share and, when issued, the Series A Preferred Stock was fully paid and non-assessable. The Series
A Preferred Stock, ranks senior to all other Company capital stock unless required holder votes are obtained to create a class of stock
senior to Series A Preferred Stock. The requisite holders of Series A Preferred Stock consented to the issuance of the Series C Preferred
Stock described below, which ranks senior